학술논문
2023 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium Meeting highlights.
Document Type
Proceedings
Author
Source
Subject
*CONFERENCES & conventions
*KIDNEY tumors
*PROSTATE tumors
BLADDER tumors
GENITOURINARY organ tumors
*
*
Language
ISSN
1911-6470
Abstract
The article offers information on the 2023 American Society of Clinical Oncology Genitourinary (GU) Cancers Symposium, held in California and online on February 16–18, 2023 focused on study findings in the diagnosis and treatment of GU malignancies. Topics include the benefits of PARP inhibitors in the treatment of metastatic castration-resistant prostate cancer; the potential use of utDNA as a biomarker in bladder cancer; and the importance of patient stratification based on genetic markers.